AR020328A1 - Mumbaistatina, un proceso para su produccion, composiciones farmaceuticas, la especie streptomyces, y el uso de membaistatina para la manufactura de unmedicamento - Google Patents
Mumbaistatina, un proceso para su produccion, composiciones farmaceuticas, la especie streptomyces, y el uso de membaistatina para la manufactura de unmedicamentoInfo
- Publication number
- AR020328A1 AR020328A1 ARP990102990A ARP990102990A AR020328A1 AR 020328 A1 AR020328 A1 AR 020328A1 AR P990102990 A ARP990102990 A AR P990102990A AR P990102990 A ARP990102990 A AR P990102990A AR 020328 A1 AR020328 A1 AR 020328A1
- Authority
- AR
- Argentina
- Prior art keywords
- mumbaistatin
- pharmaceutically acceptable
- manufacture
- production
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Mumbaistatina, un compuesto de la formula molecular C28H20O12 que se caracteriza por su espectro de RNM de 1H y su espectro de RNM de 13Cy sus sales y derivados farmacéuticamente aceptables, en todas sus formas estereoisoméricas y tautoméricas. Serelaciona con un compuestodenominado Mumbaistatina que se obtiene mediante el cultivo del microorganismo HIL-008003 DSM 11641) y con sus sales y derivados farmacéuticamente aceptables.La Mumbaistatina es un inhibidor de la glucosa-6-fosfato translocasa y se puede emplear en el tratamiento de la diabetes mellitus. Se relaciona asimismo con unproceso para la produccion de Mumbaistatina, con el microorganismo HIL-008003 (DSM 11641), con el uso de la Mumbaistatina y sus sales y derivadosfarmacéuticamente aceptables como productos farmacéuticos, en especial con su uso para la manufactura de un medicamento en el tratamiento de la diabetesmellitus y con composiciones farmacéuticas que contienen Mumbaistatina o una sal o derivado farmacéuticamenteaceptable de la misma.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98111636 | 1998-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR020328A1 true AR020328A1 (es) | 2002-05-08 |
Family
ID=8232164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990102990A AR020328A1 (es) | 1998-06-24 | 1999-06-22 | Mumbaistatina, un proceso para su produccion, composiciones farmaceuticas, la especie streptomyces, y el uso de membaistatina para la manufactura de unmedicamento |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6297043B1 (es) |
| EP (1) | EP1090136B1 (es) |
| JP (1) | JP4287593B2 (es) |
| KR (1) | KR20010071564A (es) |
| CN (1) | CN1306580A (es) |
| AR (1) | AR020328A1 (es) |
| AT (1) | ATE328103T1 (es) |
| AU (1) | AU750509B2 (es) |
| BR (1) | BR9912200A (es) |
| CA (1) | CA2336135A1 (es) |
| DE (1) | DE69931633T2 (es) |
| HU (1) | HUP0102370A3 (es) |
| ID (1) | ID27411A (es) |
| PL (1) | PL345192A1 (es) |
| RU (1) | RU2221870C2 (es) |
| TR (1) | TR200003570T2 (es) |
| WO (1) | WO1999067408A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL205217B1 (pl) * | 1999-10-25 | 2010-03-31 | Sanofi Aventis Deutschland | Aromatyczne pochodne diketonowe i kompozycja farmaceutyczna zawierająca aromatyczne pochodne diketonowe |
| US7659102B2 (en) | 2001-02-21 | 2010-02-09 | Verenium Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
| JP2004533219A (ja) | 2001-02-21 | 2004-11-04 | ディヴァーサ コーポレイション | αアミラーゼ活性を有する酵素及びその使用方法 |
| WO2004042006A2 (en) | 2002-10-31 | 2004-05-21 | Diversa Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
| JP6465299B2 (ja) * | 2015-05-29 | 2019-02-06 | 株式会社山田養蜂場本社 | 蜂蜜画分 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL176369C (nl) * | 1973-06-22 | 1985-04-01 | Gen Electric | Werkwijze ter bereiding van polyetherimiden, en voorwerpen daaruit vervaardigd. |
| US3905942A (en) | 1973-06-22 | 1975-09-16 | Gen Electric | Method for making polyetherimides and products produced thereby |
| TW399041B (en) * | 1992-09-09 | 2000-07-21 | Hoechst Ag | Substituted cyclohexane derivatives, the preparation and the use for treating diseases |
| TW255880B (es) * | 1992-09-09 | 1995-09-01 | Hoechst Ag |
-
1999
- 1999-06-15 BR BR9912200-6A patent/BR9912200A/pt not_active IP Right Cessation
- 1999-06-15 RU RU2001102052/13A patent/RU2221870C2/ru not_active IP Right Cessation
- 1999-06-15 WO PCT/EP1999/004127 patent/WO1999067408A1/en not_active Ceased
- 1999-06-15 AT AT99927987T patent/ATE328103T1/de not_active IP Right Cessation
- 1999-06-15 KR KR1020007014590A patent/KR20010071564A/ko not_active Ceased
- 1999-06-15 DE DE69931633T patent/DE69931633T2/de not_active Expired - Lifetime
- 1999-06-15 HU HU0102370A patent/HUP0102370A3/hu unknown
- 1999-06-15 CA CA002336135A patent/CA2336135A1/en not_active Abandoned
- 1999-06-15 EP EP99927987A patent/EP1090136B1/en not_active Expired - Lifetime
- 1999-06-15 JP JP2000556048A patent/JP4287593B2/ja not_active Expired - Fee Related
- 1999-06-15 AU AU45137/99A patent/AU750509B2/en not_active Ceased
- 1999-06-15 PL PL99345192A patent/PL345192A1/xx unknown
- 1999-06-15 ID IDW20002718A patent/ID27411A/id unknown
- 1999-06-15 CN CN99807685A patent/CN1306580A/zh active Pending
- 1999-06-15 TR TR2000/03570T patent/TR200003570T2/xx unknown
- 1999-06-22 AR ARP990102990A patent/AR020328A1/es unknown
- 1999-06-23 US US09/338,601 patent/US6297043B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6297043B1 (en) | 2001-10-02 |
| ID27411A (id) | 2001-04-05 |
| HUP0102370A3 (en) | 2003-10-28 |
| DE69931633T2 (de) | 2007-05-10 |
| CN1306580A (zh) | 2001-08-01 |
| AU750509B2 (en) | 2002-07-18 |
| ATE328103T1 (de) | 2006-06-15 |
| JP2002518057A (ja) | 2002-06-25 |
| DE69931633D1 (de) | 2006-07-06 |
| CA2336135A1 (en) | 1999-12-29 |
| KR20010071564A (ko) | 2001-07-28 |
| TR200003570T2 (tr) | 2001-04-20 |
| EP1090136B1 (en) | 2006-05-31 |
| WO1999067408A1 (en) | 1999-12-29 |
| HUP0102370A2 (hu) | 2001-10-28 |
| RU2221870C2 (ru) | 2004-01-20 |
| AU4513799A (en) | 2000-01-10 |
| EP1090136A1 (en) | 2001-04-11 |
| JP4287593B2 (ja) | 2009-07-01 |
| PL345192A1 (en) | 2001-12-03 |
| BR9912200A (pt) | 2001-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220380285A1 (en) | Prenylated hydroxystilbenes | |
| US6936638B2 (en) | Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto | |
| ES2017837A6 (es) | Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales. | |
| CR8147A (es) | Derivados de pirido 2, 1a-isoquinolina, como inhibidores de dpp-iv | |
| AR062394A1 (es) | Uso de compuestos y derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis | |
| UY28489A1 (es) | Glucopiranosiloxi-pirazoles, medicamentos que contienen estos compuestos, su uso y procedimiento para su preparación | |
| GT200100147A (es) | Derivados de imidazol | |
| ECSP066855A (es) | Derivados de benceno sustituidos por glucopiranosilo, medicamentos que contienen esos compuestos, su aplicación y procedimiento para su preparación | |
| UY27605A1 (es) | Nuevos derivados de pirido (2,1-)siquinolina | |
| BRPI0519106A2 (pt) | compostos, uso destes, processo para sua fabricaÇço, composiÇÕes farmacÊuticas, mÉtodo para o tratamento e/ou profilaxia de doenÇas que sço associadas com a dpp-iv | |
| ES2013067A6 (es) | Un procedimiento para producir un derivado de piperazina. | |
| ES2178724T3 (es) | Acidos arilsulfonamido hidroxamicos alfa-sustituidos como inhibidores de factor de necrosis tumoral alfa y de metaloproteinasas de matriz. | |
| ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
| NO20024772D0 (no) | Percyquinnin, fremgangsmåte for dets fremstilling og dets anvendelse som et legemiddel | |
| AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
| ATE541854T1 (de) | Pyrazolderivat, arzneimittelzusammensetzung, die dieses enthält, und zwischenprodukt für dessen herstellung | |
| MX2022002339A (es) | Derivados de alfa-d-galactopiranosido. | |
| CL2025000672A1 (es) | Compuestos derivados de aminopirimidina, inhibidores de cdk2; composición farmacéutica; uso para tratar cáncer. | |
| AR020328A1 (es) | Mumbaistatina, un proceso para su produccion, composiciones farmaceuticas, la especie streptomyces, y el uso de membaistatina para la manufactura de unmedicamento | |
| BR112023025793A2 (pt) | Composto de fórmula (ii), um estereoisômero deste ou um sal farmaceuticamente aceitável deste, composição farmacêutica e uso do composto | |
| UY27324A1 (es) | Nuevas sales de napsilato i | |
| ES2086442T3 (es) | Derivados de fluoroetilcamptotecina. | |
| AR025380A1 (es) | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus. | |
| AR024226A1 (es) | Vancorresmicina, un proceso para su produccion, un cultivo de microorganismos para su preparacion, composicion farmaceutica que la contiene | |
| AR106180A2 (es) | COMPUESTO DE a-AMINOCARBOXIAMIDA QUE ES 5-(4-{[(2-FLUOROFENIL)METIL]OXI}FENIL)PROLINAMIDA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |